Skip to main content

Advertisement

Table 1 Basic characteristics of patients

From: Clinical outcomes of graves’ ophthalmopathy treated with intensity modulated radiation therapy

Variables No. Percent
Gender   
 Female 64 55.2%
 Male 52 44.8%
Previous thyroid treatment   
 Medication 84 72.4%
 Thyroidectomy 14 12.1%
 RAI 43 37.1%
 None 20 17.2
Smoking status   
 Current smoker 42 36.2%
 Former smoker 11 9.5%
 Non-smoker 63 54.3%
Duration of GO prior to RT   
  ≤ 6 months 41 35.3%
 6–18 months 48 41.4%
  > 18 months 27 23.3%
Previous steroid use   
 Yes 39 33.6%
 No 77 66.4%
Response to previous steroids   
 None 10 25.6%
 Mild to moderate 29 74.4%
 Significant 0 0%
Concurrent steroid use during RT   
 Yes 21 18.1%
 No 95 81.9%
Symptom severity scores at enrollment   
 2 to 5 32 27.6%
 6 to 10 63 54.3%
 11 to 14 21 18.1%
  1. RAI radioactive iodine, GO Graves’ ophthalmopathy, RT Radiation therapy